A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus aureusSequence Type 5 Lineage

MLA

Khan, Ayesha, et al. “A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus AureusSequence Type 5 Lineage.” Journal of Clinical Microbiology, vol. 57, no. 9, June 2019. EBSCOhost, https://doi.org/10.1128/JCM.00798-19.

APA

Khan, A., Rivas, L. M., Spencer, M., Martinez, R., Lam, M., Rojas, P., Porte, L., Silva, F., Braun, S., Valdivieso, F., Mv¨lhauser, M., Lafourcade, M., Miller, W. R., García, P., Arias, C. A., & Munita, J. M. (2019). A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus aureusSequence Type 5 Lineage. Journal of Clinical Microbiology, 57(9). https://doi.org/10.1128/JCM.00798-19

Chicago

Khan, Ayesha, Lina M. Rivas, Maria Spencer, Rodrigo Martinez, Marusella Lam, Pamela Rojas, Lorena Porte, et al. 2019. “A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus AureusSequence Type 5 Lineage.” Journal of Clinical Microbiology 57 (9). doi:10.1128/JCM.00798-19.